AIM
BLFS icon

Aigen Investment Management’s BioLife Solutions BLFS Stock Holding History

Aigen Investment Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-986
Closed -$16K – 1275
2019
Q4 		$16K Buy
+986
New +$16K ﹤0.01% 932

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SPA
Sentinel Pension Advisors Wakefield, Massachusetts $676M AUM 15.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Aigen Investment Management's BLFS Position: Q1 2020 in Review

Aigen Investment Management sold out of BioLife Solutions (BLFS) in Q1 2020, closing a stake of 986 shares — an estimated $16K sold.

Aigen Investment Management first reported a position in BLFS in Q4 2019 and held it in 1 quarter. The position peaked at $16K in Q4 2019. 75 funds tracked by Wall St. Rank hold BLFS as of Q1 2020.

  • Aigen Investment Management reported no remaining BioLife Solutions position as of Q1 2020 after selling out during the quarter.
  • Aigen Investment Management sold 986 BioLife Solutions shares in Q1 2020, an estimated $16K.
  • Aigen Investment Management first reported a position in BioLife Solutions in Q4 2019 and held it in 1 quarter.
  • Aigen Investment Management's BioLife Solutions position peaked at $16K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2020.

Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.